Overview / Abstract: |
STATEMENT OF NEED Sarcomas, which represent 1% to 2% of adult cancers, are a rare, heterogeneous group of neoplasms originating in the connective tissue. Soft tissue sarcomas, which begin in the muscle, tendons, fat, lymph, blood vessels, and nerves, encompass more than 80 histological subtypes. Approximately 25% of patients develop metastatic disease after curative-intent surgery, and for these patients, treatment options are limited and prognosis is very poor. In recent decades, the identification of genetic alterations in soft tissue sarcoma has led to the rise of targeted therapy, significantly expanding the therapeutic landscape. Remaining up to date on pathological characteristics and emerging data on novel therapies is crucial (Riskjell et al, 2023; NCI, 2023). In this Virtual Tumor Board, Shreyaskumar R. Patel, MD, Medical Director of the Sarcoma Center at the University of Texas MD Anderson Cancer Center; Kathleen Polson, NP, Nurse Practitioner at Dana-Farber Cancer Institute; and Brian Rubin, MD, PhD, Professor of Pathology at Cleveland Clinic Cancer Center, will present cases and explore multidisciplinary strategies to optimize treatment outcomes for patients with advanced soft tissue sarcoma. TARGET AUDIENCE Medical/surgical/radiation oncologists, pathologists, nurse practitioners, physician assistants, oncology nurses, and other health care professionals involved in the treatment of patients with soft tissue sarcoma. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to Distinguish patient and tumor characteristics that can inform personalized therapeutic approaches in soft tissue sarcoma |
Expiration |
Aug 09, 2024 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1.5 CME | 1.5 NCPD | 1.5 MOC | 1.5 ILNA |
Accreditation |
ACCME, ANCC, ONCC |
Presenters / Authors / Faculty |
Shreyaskumar R. Patel, MD Kathleen Polson, NP Brian Rubin, MD, PhD |
Sponsors / Supporters / Grant Providers |
This activity has been supported by educational grants from Bayer Healthcare Pharmaceuticals Inc and Ipsen. |
Keywords / Search Terms |
i3 Health i3 Health Oncology, i3 Health, CME, NCPD, free CNE, free NCPD, Free CE, Free CME, Nursing, Oncology Nursing, Physician, Oncologist, nurse practitioner, physician assistants, oncology nurse, Medical oncologists, fellows, hematology Free CE CME Free CE CME |